METHOD FOR DETERMINING TREATMENT OF INDIVIDUALS WITH FRAGILE SITE

Provided are methods for determining a chemotherapy treatment for an individual diagnosed with or suspected of having cancer, a method for assisting in the development of a therapeutic plan for an individual and for determining whether a chemotherapeutic agent can induce breakage of a FRA12E fragile...

Full description

Saved in:
Bibliographic Details
Main Author COIGNET, LIONEL, J
Format Patent
LanguageEnglish
French
Published 11.12.2008
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided are methods for determining a chemotherapy treatment for an individual diagnosed with or suspected of having cancer, a method for assisting in the development of a therapeutic plan for an individual and for determining whether a chemotherapeutic agent can induce breakage of a FRA12E fragile site. L'invention concerne des méthodes destinées à déterminer une chimiothérapie pour un individu chez lequel un cancer a été diagnostiqué ou la présence d'un cancer suspectée, ainsi qu'une méthode destinée à faciliter l'élaboration d'un plan thérapeutique pour un individu et à déterminer si un agent chimiothérapeutique peut induire une rupture d'un site fragile FRA12E.
Bibliography:Application Number: WO2007US19702